Bullfrog AI Holdings, Inc. (BFRG)
NASDAQ: BFRG · Real-Time Price · USD
2.090
-0.020 (-0.95%)
At close: Dec 20, 2024, 4:00 PM
2.110
+0.020 (0.96%)
After-hours: Dec 20, 2024, 4:55 PM EST
Bullfrog AI Revenue
In the year 2023, Bullfrog AI had annual revenue of $65.00K with 550.00% growth.
Revenue (ttm)
$65.00K
Revenue Growth
+550.00%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
18.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65.00K | 55.00K | 550.00% |
Dec 31, 2022 | 10.00K | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBFRG News
- 4 days ago - BullFrog AI Announces Appointment of Chief Financial Officer - GlobeNewsWire
- 2 months ago - BullFrog AI's VP Artificial Intelligence to Present at Google's Cancer AI Symposium - GlobeNewsWire
- 2 months ago - WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million - PRNewsWire
- 2 months ago - Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million - GlobeNewsWire
- 2 months ago - WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million - PRNewsWire
- 2 months ago - Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million - GlobeNewsWire
- 2 months ago - BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni - GlobeNewsWire
- 2 months ago - BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114 - GlobeNewsWire